{"text": "Second, at phases 7 and 9, depressive symptoms were also assessed using the Center for Epidemiologic Studies Depression Scale (CES-D) (note that CES-D was not included in earlier screening phases of our study) (29).", "sentId": 1, "start": 0, "end": 215}
{"text": "The 20 items of the CES-D measure symptoms associated with depression; participants are asked to score the frequency of occurrence of specific symptoms during the previous week on a four point scale (0 = less than one day, 1 = 1–2 days, 2 = 3–4 days, and 3 = 5–7 days).", "sentId": 2, "start": 216, "end": 485}
{"text": "These items are summed to yield a total score between 0 and 60, with participants scoring ≥16 defined as having CES-D depressive symptoms (30).", "sentId": 3, "start": 486, "end": 629}
{"text": "In a validation study of 274 Whitehall II participants, sensitivity and specificity were 89% and 86%, respectively, for CES-D depressive symptoms using a structured psychiatric interview as the criterion.", "sentId": 4, "start": 630, "end": 834}
